P. Junker

发表

A putative regulatory polymorphism in PD-1 is associated with nephropathy in a population-based cohort of systemic lupus erythematosus patients

A. Voss, S. Husby, S. Lillevang, 2004, Lupus.

Circadian, Week-to-Week, and Physical Exercise-Induced Variation of Serum Microfibrillar-Associated Protein 4

H. Nielsen, P. Junker, G. Sorensen, 2021, Biomarker insights.

Prognostic value of renal biopsy and clinical variables in patients with lupus nephritis and normal serum creatinine.

A. Voss, H. Starklint, P. Junker, 1999, Scandinavian journal of rheumatology.

Hepcidin plasma levels are not associated with changes in haemoglobin in early rheumatoid arthritis patients

K. Stengaard-Pedersen, H. Glerup, P. Junker, 2017, Scandinavian journal of rheumatology.

Patterns of Magnetic Resonance Imaging Bone Erosion in Rheumatoid Arthritis — Which Bones Are Most Frequently Involved and Show the Most Change?

M. Østergaard, K. Stengaard-Pedersen, P. Junker, 2011, The Journal of Rheumatology.

Long-term stability and circadian variation in circulating levels of surfactant protein D.

H. Nielsen, U. Holmskov, P. Junker, 2010, Immunobiology.

Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis

K. Stengaard-Pedersen, P. Junker, K. Hørslev-Petersen, 2022, Scandinavian journal of rheumatology.

Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis

M. Østergaard, K. Stengaard-Pedersen, P. Junker, 2014, Arthritis Research & Therapy.

FRI0067 Changes in Multi-Biomarker Disease Activity (MBDA) Score Correlate with Changes in Established Disease Activity Measurements in Patients with Early Ra from The Opera Study

C. Brahe, P. Junker, N. Defranoux, 2016 .

WILLINGNESS TO PAY FOR ARTHRITIS SYMPTOM ALLEVIATION

P. Junker, M. L. Larsen, U. Slothuus, 2000, International Journal of Technology Assessment in Health Care.

Survival in systemic lupus erythematosus, 1995–2010. A prospective study in a Danish community

A. Voss, J. Hjelmborg, H. Laustrup, 2013, Lupus.

SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study

A. Voss, H. Laustrup, P. Junker, 2010, Lupus.

Occurrence of systemic lupus erythematosus in a Danish community: an 8‐year prospective study

A. Voss, H. Laustrup, P. Junker, 2009, Scandinavian journal of rheumatology.

Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.

Javier Martín, M. Alarcón‐Riquelme, S. Kozyrev, 2007, Arthritis and rheumatism.

A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value

A. Voss, P. Junker, J. Pødenphant, 2005, Clinical Rheumatology.

A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets

A. Voss, P. Junker, J. Pødenphant, 2005, Clinical Rheumatology.

Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2015, Scandinavian journal of rheumatology.

Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis

M. Karsdal, A. Loft, P. Junker, 2016, Arthritis Research & Therapy.

No diagnostic utility of antibody patterns against Klebsiella pneumoniae capsular serotypes in patients with axial spondyloarthritis vs. patients with non-specific low back pain: a cross-sectional study

A. Loft, M. Østergaard, T. Barington, 2017, Scandinavian journal of rheumatology.

Serum hyaluronan is increased in malignant lymphoma

N. Nissen, H. Hasselbalch, D. Hovgaard, 1995, American journal of hematology.

Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine.

A. Engström‐Làurent, P. Junker, K. Hørslev-Petersen, 1988, Annals of the rheumatic diseases.

Programmed death ligand 2 – A link between inflammation and bone loss in rheumatoid arthritis

G. Freeman, S. Moestrup, A. Sharpe, 2019, Journal of translational autoimmunity.

Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus.

A. Voss, P. Junker, J. Pødenphant, 1999, Scandinavian journal of rheumatology.

THU0272 BASEMENT MEMBRANE SEROLOGICAL MARKERS OF COLLAGEN TYPE IV AND LAMININ REMODELING ARE DIFFERENTIALLY EXPRESSED IN SLE

S. Kay, A. Voss, P. Junker, 2020, Annals of the Rheumatic Diseases.

[Connective tissue metabolites in tissue fluids. New possibilities for monitoring the fibrotic process].

P. Junker, K. Hørslev-Petersen, K. Bentsen, 1986, Ugeskrift for laeger.

Retroperitoneal fibrosis as the presenting manifestation of IgG4-related disease in a patient previously diagnosed with granulomatosis with polyangiitis (Wegener’s): one disease or two?

N. Marcussen, P. Junker, N. Lomborg, 2014, Scandinavian journal of rheumatology.

D-penicillamine-induced angiopathy in rats. The effect of high dose D-penicillamine treatment on aortic permeability to albumin and on the ultrastructure of the vessel.

B. A. Jensen, J. Chemnitz, P. Junker, 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.

YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization.

P. Junker, J. Johansen, N. Borregaard, 1999, The Journal of infectious diseases.

Surfactant protein-D, a potential mediator of inflammation in axial spondyloarthritis

L. Christiansen, K. Kyvik, U. Holmskov, 2018, Rheumatology.

The D‐vitamin metabolite 1,25(OH)2D in serum is associated with disease activity and Anti‐Citrullinated Protein Antibodies in active and treatment naïve, early Rheumatoid Arthritis Patients

P. Vestergaard, M. Østergaard, K. Stengaard-Pedersen, 2018, Scandinavian journal of immunology.

Increased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis subsets

M. Østergaard, P. Junker, K. Hørslev-Petersen, 2017, Arthritis Research & Therapy.

Syddansk Universitet Increased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis

M. Østergaard, P. Junker, K. Hørslev-Petersen, 2017 .

Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity.

U. Holmskov, P. Junker, G. Sorensen, 2019, Clinical and experimental rheumatology.

Site‐specific absence of microfibrillar‐associated protein 4 (MFAP4) from the internal elastic membrane of arterioles in the rheumatoid arthritis synovial membrane: an immunohistochemical study in patients with advanced rheumatoid arthritis versus osteoarthritis

F. B. Sørensen, P. Junker, G. Sorensen, 2019, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial

C. Brahe, K. Stengaard-Pedersen, T. Ellingsen, 2018, Scandinavian journal of rheumatology.

Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind

L. Hanson, M. Østergaard, K. Stengaard-Pedersen, 2017, Scandinavian journal of rheumatology.

Expression of soluble CD83 in plasma from early‐stage rheumatoid arthritis patients is not modified by anti‐TNF‐&agr; therapy

P. Höllsberg, K. Stengaard-Pedersen, P. Junker, 2017, Cytokine.

Within‐day variation and influence of physical exercise on circulating Galectin‐3 in patients with rheumatoid arthritis and healthy individuals

P. Junker, K. Hørslev-Petersen, H. Lindegaard, 2015, Scandinavian journal of immunology.

Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial

J. K. Pedersen, T. Ellingsen, P. Junker, 2013, Annals of the rheumatic diseases.

A non-synonymous single-nucleotide polymorphism in the gene encoding Toll-like Receptor 3 (TLR3) is associated with sero-negative Rheumatoid Arthritis (RA) in a Danish population

Bettina Hansen, K. Stengaard-Pedersen, M. Laska, 2014, BMC Research Notes.

Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression

K. Stengaard-Pedersen, J. K. Pedersen, T. Ellingsen, 2014, Scandinavian journal of rheumatology.

Diurnal variation of connective tissue metabolites in early and long-standing rheumatoid arthritis and in healthy individuals

P. Junker, K. Hørslev-Petersen, T. Lottenburger, 2011, Scandinavian journal of rheumatology.

Circadian rhythm and the influence of physical activity on circulating surfactant protein D in early and long-standing rheumatoid arthritis

U. Holmskov, P. Junker, I. Tornøe, 2011, Rheumatology International.

The Programmed Death-1 Pathway Counter-Regulates Inflammation-Induced Osteoclast Activity in Clinical and Experimental Settings

G. Freeman, S. Moestrup, A. Sharpe, 2022, Frontiers in Immunology.

Palpable Purpura with an Unexpected Outcome

O. Clemmensen, P. Junker, Anne Friesgaard Christensen, 2013, Case Reports in Rheumatology.

Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men.

J. Bollerslev, J. Gram, P. Junker, 1998, Bone.

A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial

M. Østergaard, K. Stengaard-Pedersen, H. C. Horn, 2014, Annals of the rheumatic diseases.

Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation studies based on the CIMESTRA and OPERA tria

C. Brahe, K. Stengaard-Pedersen, T. Ellingsen, 2018, Scandinavian journal of rheumatology.

Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents

Xingmin Feng, J. Bussel, H. Hasselbalch, 2011, British journal of haematology.

Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical Trial

M. Østergaard, K. Stengaard-Pedersen, T. Ellingsen, 2018, The Journal of Rheumatology.

Placebo-controlled Clinical Trial Responding to Adalimumab plus Methotrexate vs Methotrexate Alone : A Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis

M. Østergaard, K. Stengaard-Pedersen, T. Ellingsen, 2017 .

Short title for running head: Vitamin D in early Rheumatoid Arthritis

T. Ellingsen, P. Junker, K. Hørslev-Petersen, 2018 .

Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia.

U. Holmskov, P. Junker, C. Koch, 2003, Clinical immunology.

Polymorphisms within Toll-like receptors are associated with systemic lupus erythematosus in a cohort of Danish females.

Bettina Hansen, A. Voss, K. Stengaard-Pedersen, 2014, Rheumatology.

Dose-response effect of short-term calcitriol treatment on bone and mineral metabolism in normal males.

J. Bollerslev, J. Gram, P. Junker, 1996, Bone.

IVIG treatment for progressive stroke in the primary antiphospholipid antibody syndrome

H. C. Horn, P. Junker, K. Grau, 2004, Lupus.

Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial.

K. Stengaard-Pedersen, P. Junker, K. Hørslev-Petersen, 2022, Scandinavian journal of rheumatology.

D-penicillamine in rheumatoid arthritis

P. Junker, 1986, Indian journal of pediatrics.

S. Möller, R. Christensen, M. Østergaard, 2021, Rheumatology International.

Circadian pattern and the effect of standardized physical exercise on procollagen IIA N-peptide (PIIANP) in rheumatoid arthritis at different stages and in healthy individuals

P. Junker, K. Hørslev-Petersen, H. Lindegaard, 2010, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Differential association of the N-propeptide of collagen IIA (PIIANP) and collagen II C-telopeptide (CTX-II) with synovitis and erosions in early and longstanding rheumatoid arthritis.

P. Junker, K. Hørslev-Petersen, H. Lindegaard, 2009, Clinical and experimental rheumatology.

Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: Relation to disease activity and effect of chemotherapy

H. Hasselbalch, I. Lisse, P. Junker, 1990, American journal of hematology.

Circulating Surfactant Protein D is Decreased in Early Rheumatoid Arthritis: A 1‐year Prospective Study

C. Bendixen, U. Holmskov, P. Junker, 2007, Scandinavian journal of immunology.

Low field dedicated magnetic resonance imaging in untreated rheumatoid arthritis of recent onset

M. Østergaard, P. Junker, K. Hørslev-Petersen, 2001, Annals of the rheumatic diseases.

The occurrence of psoriatic arthritis in Denmark

A. Skytthe, P. Junker, O. Pedersen, 2008, Annals of the rheumatic diseases.

Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial

M. Østergaard, K. Stengaard-Pedersen, H. C. Horn, 2013, Annals of the rheumatic diseases.

Connective tissue responses in acute community-acquired pneumonia.

P. Junker, B. Teisner, C. Nordenbaek, 2003, Respiratory medicine.

Surfactant protein D is decreased in rheumatoid arthritis

U. Holmskov, G. Hansen, K. Stengaard-Pedersen, 2008 .

Patterns of MRI Bone Erosion in Rheumatoid Arthritis - Which Bones Are Most Frequently Involved and Show Most Change?

M. Østergaard, K. Stengaard-Pedersen, P. Junker, 2010 .

Serum amino-terminal type III procollagen peptide in rheumatoid arthritis. Relationship to disease activity, treatment, and development of joint erosions.

P. Junker, K. Hørslev-Petersen, I. Lorenzen, 1986, Arthritis and rheumatism.

Risk of Lymphoma and Solid Cancer among Patients with Rheumatoid Arthritis in a Primary Care Setting

H. Vestergaard, H. Hasselbalch, C. Andersen, 2014, PloS one.

Systemic adverse events following rituximab therapy in patients with Graves’ disease

L. Hegedüs, H. Hasselbalch, C. Nielsen, 2010, Journal of endocrinological investigation.

[Low back pain].

M. Kosteljanetz, T. Bendix, K. Stengaard-Pedersen, 1996, Ugeskrift for laeger.

Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on thrombopoietin receptor agonist treatment

Xingmin Feng, J. Bussel, P. Junker, 2019, Platelets.

Single test isolated lupus anticoagulant positivity is associated with increased plasma levels of inflammatory markers and dyslipidemia

H. Laustrup, P. Junker, I. Hansen, 2016, Lupus.

Interleukin-23 in early disease development in rheumatoid arthritis

M. Østergaard, K. Stengaard-Pedersen, P. Junker, 2015, Scandinavian journal of rheumatology.

Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs.

H. Møller, M. Østergaard, K. Stengaard-Pedersen, 2015, Clinical and experimental rheumatology.

Outreach screening of drug users for cirrhosis with transient elastography.

M. Vyberg, P. Junker, C. Pedersen, 2011, Addiction.

Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.

O. B. Schaffalitzky de Muckadell, J. Kjeldsen, P. Junker, 1995, Gut.

Increased serum concentrations of type I procollagen C-terminal propeptide and osteocalcin during a short course of calcitriol administration to adult male volunteers.

J. Bollerslev, J. Gram, P. Junker, 1991, Acta endocrinologica.

FRI0607 Effect of Methotrexate and Intra-Articular Betamethasone with or Without Additional Cyclosporine on Magnetic Resonance Imaging (MRI)-Determined Inflammatory and Destructive Changes in Very Early Rheumatoid Arthritis – Results from a 24-Months' Randomised Double Blind Placebo Controlled Trial

K. Stengaard-Pedersen, J. K. Pedersen, T. Ellingsen, 2015 .

Circulating hyaluronan in the myelofibrosis/osteomyelosclerosis syndrome and other myeloproliferative disorders

H. Hasselbalch, I. Lisse, P. Junker, 1991, American journal of hematology.

Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long-term follow-up study.

P. Junker, K. Hørslev-Petersen, E. Juhl, 2008, Liver.

D-penicillamine-induced angiopathy in rats. Changes in aortic collagen, glycosaminoglycans, DNA and RNA in rats treated with D-penicillamine.

B. A. Jensen, H. Oxlund, P. Junker, 1982, Atherosclerosis.

Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA)

M. Østergaard, K. Stengaard-Pedersen, T. Ellingsen, 2015, Annals of the rheumatic diseases.

Hepatic and renal extraction of circulating type I procollagen aminopropeptide in patients with normal liver function and in patients with alcoholic cirrhosis.

J. Henriksen, P. Junker, B. Teisner, 1999, Scandinavian journal of clinical and laboratory investigation.

On the applicability of the CASPAR criteria in psoriatic arthritis

P. Junker, O. Pedersen, 2008, Annals of the rheumatic diseases.

Type IV collagen metabolism is associated with disease activity, radiographic progression and response to tocilizumab in rheumatoid arthritis.

M. Karsdal, P. Junker, N. Gudmann, 2018, Clinical and experimental rheumatology.

Wegener's Granulomatosis Presenting with Pachymeningitis: Clinical and Imaging Remission by Rituximab

P. Junker, M. K. Nielsen, S. A. Just, 2011, ISRN rheumatology.

Third Eular Workshop on Rheumatology Research

C. Forbes, R. Madhok, A. Cats, 1983, Clinical Rheumatology.

Fibronectin in experimental granulation tissue.

I. Clemmensen, P. Junker, B. Hølund, 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.

Serum procollagen III peptide in chronic myeloproliferative disorders.

H. Hasselbalch, I. Lisse, P. Junker, 2009, Scandinavian journal of haematology.

Adaptation of the Bath measures on disease activity and function in ankylosing spondylitis into Danish

P. Junker, O. Pedersen, A. Svendsen, 2007, Scandinavian journal of rheumatology.

Serum aminoterminal type III procollagen peptide in inflammatory and degenerative rheumatic disorders

F. Mathiesen, P. Junker, K. Hørslev-Petersen, 1988, Clinical Rheumatology.

Double-blind trial of levamisole, penicillamine and azathioprine in rheumatoid arthritis. Clinical, biochemical, radiological and scintigraphic studies.

P. Junker, P. Halberg, I. Lorenzen, 1984, Danish medical bulletin.

Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab—a substudy of the optimized treatment algorithm in early RA (OPERA) trial

H. Bliddal, K. Stengaard-Pedersen, H. C. Horn, 2017, Clinical Rheumatology.

Circulating surfactant protein -D is low and correlates negatively with systemic inflammation in early, untreated rheumatoid arthritis

U. Holmskov, M. Østergaard, K. Stengaard-Pedersen, 2010, Arthritis research & therapy.

Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2012, Annals of the rheumatic diseases.

HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.

M. Rubini, R. Rizzo, M. Stignani, 2008, Tissue antigens.

Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts

R. Cummings, M. Østergaard, K. Stengaard-Pedersen, 2023, Cells.

On the heritability of psoriatic arthritis. Disease concordance among monozygotic and dizygotic twins

A. Skytthe, P. Junker, O. Pedersen, 2008, Annals of the rheumatic diseases.

CXCL13 predicts long term radiographic status in early rheumatoid arthritis.

M. Østergaard, P. Junker, B. Deleuran, 2021, Rheumatology.

CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic ‘window of opportunity’

Peter Junker, M. Østergaard, K. Stengaard-Pedersen, 2014, Arthritis Research & Therapy.

Shrinking spinal cord following transverse myelopathy in a patient with systemic lupus erythematosus and the phospholipid antibody syndrome.

P. Junker, V. Schantz, L. Oestergaard, 1998, The Journal of rheumatology.

Collagen metabolism and enzymes of the urokinase plasminogen activator system in chronic myeloproliferative disorders: correlation between plasma‐soluble urokinase plasminogen activator receptor and serum markers for collagen metabolism

N. Brünner, R. Riisbro, M. Jensen, 2003, European journal of haematology.

Bone marrow stroma in idiopathic myelofibrosis and other haematological diseases.

H. Hasselbalch, P. Junker, I. Lisse, 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Serum markers for type IV collagen and type III procollagen in the myelofibrosis‐osteomyelosclerosis syndrome and other chronic myeloproliferative disorders

J. Risteli, H. Hasselbalch, I. Lisse, 1986, American journal of hematology.

Serum laminin P1 in idiopathic myelofibrosis and related diseases.

H. Hasselbalch, P. Junker, 1994, Leukemia research.

Differentially Methylated DNA Regions in Monozygotic Twin Pairs Discordant for Rheumatoid Arthritis: An Epigenome-Wide Study

L. Christiansen, R. Lyle, K. Kyvik, 2016, Front. Immunol..

Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus

Sandra D'Alfonso, Torsten Witte, Marta E Alarcón-Riquelme, 2008, Nature Genetics.

Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE)

H. Marquart, C. Nielsen, P. Junker, 1995, Clinical and experimental immunology.

Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27

A. Loft, P. Junker, N. Gudmann, 2016, Rheumatology International.

Heritability assessment of cartilage metabolism. A twin study on circulating procollagen IIA N-terminal propeptide (PIIANP).

K. Kyvik, J. Hjelmborg, P. Junker, 2014, Osteoarthritis and cartilage.

Uncoupling of Collagen II Metabolism in Newly Diagnosed, Untreated Rheumatoid Arthritis Is Linked to Inflammation and Antibodies Against Cyclic Citrullinated Peptides

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2010, The Journal of Rheumatology.

The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis

T. Saxne, P. Junker, K. Hørslev-Petersen, 2004, Rheumatology International.

Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population

P. H. Petersen, K. Kyvik, N. Holm, 2002, BMJ : British Medical Journal.

MRI Bone Oedema is the Strongest Predictor of Subsequent Radiographic Progression in Early RA: Results from a 2 Year Randomized Controlled Trial (CIMESTRA)

H. Thomsen, G. Hansen, M. Østergaard, 2007 .

The impact of genes on the occurrence of autoantibodies in rheumatoid arthritis. A study on disease discordant twin pairs.

K. Kyvik, A. Skytthe, J. Hjelmborg, 2013, Journal of autoimmunity.

Impact of season on the association between vitamin D levels at diagnosis and one-year remission in early Rheumatoid Arthritis

P. Vestergaard, S. Möller, M. Østergaard, 2020, Scientific Reports.

Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response

E. Hauge, M. Østergaard, K. Stengaard-Pedersen, 2016, PloS one.

Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response

Julie, E. Hauge, K. Stengaard-Pedersen, 2016 .

MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

H. Thomsen, M. Østergaard, K. Stengaard-Pedersen, 2008, Annals of the rheumatic diseases.

Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis

K. Stengaard-Pedersen, H. C. Horn, T. Ellingsen, 2015, The Pharmacogenomics Journal.

M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritis.

S. Thiel, J. Jensenius, M. Østergaard, 2013, Arthritis and rheumatism.

Syddansk Universitet Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial protocol for a cohort study with patient-record evaluated outcomes

P. Vestergaard, R. Christensen, M. Østergaard, 2017 .

Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci

H. Parving, L. Tarnow, P. Villesen, 2015, Immunologic research.

Effect of different doses of D-penicillamine and combined administration of D-penicillamine and methylprednisolone on collagen, glycosaminoglycans, DNA and RNA of granulation tissue, skin, bone and aorta in rats.

P. Junker, I. Lorenzen, G. Helin, 2009, Acta pharmacologica et toxicologica.

Effect of D-penicillamine on collagen, glycosaminoglycans, DNA and RNA of granulation tissue and connective tissue of skin, bone and aorta in rats.

P. Junker, I. Lorenzen, G. Helin, 2009, Acta pharmacologica et toxicologica.

FORMATION OF GRANULATION TISSUE IN SUBCUTANEOUSLY IMPLANTED SPONGES IN RATS

P. Junker, P. Christoffersen, I. Lorenzen, 1979, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years’ functional and radiographic outcome in early rheumatoid arthritis

K. Stengaard-Pedersen, T. Ellingsen, P. Junker, 2018, Scandinavian journal of rheumatology.

Autoantibodies in twins discordant for rheumatoid arthritis

K. Kyvik, A. Wiik, J. Hjelmborg, 2010, Annals of the rheumatic diseases.

Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study

K. Stengaard-Pedersen, J. K. Pedersen, T. Ellingsen, 2007, Annals of the rheumatic diseases.

Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients

A. Voss, P. Junker, P. Garred, 2001, Genes and Immunity.

Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation

A. Skytthe, P. Junker, O. Pedersen, 2008, Scandinavian journal of rheumatology.

Autoantibodies and self-reported health complaints in relatives of systemic lupus erythematosus patients: a community based approach

A. Voss, S. Lillevang, H. Laustrup, 2004, Lupus.

Collagen metabolites in the peripheral and splanchnic circulation of patients with Crohn disease.

O. Kronborg, O. B. Schaffalitzky de Muckadell, J. Kjeldsen, 2001, Scandinavian journal of gastroenterology.

Corrigendum: Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus

J. Wojcik, Javier Martín, L. Truedsson, 2008, Nature Genetics.

Mannose-Binding Lectin Gene Polymorphisms Are Associated with Disease Activity and Physical Disability in Untreated, Anti-Cyclic Citrullinated Peptide-Positive Patients with Early Rheumatoid Arthritis

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2009, The Journal of Rheumatology.

Circulating Surfactant Protein D Is Decreased in Systemic Lupus Erythematosus

C. Bendixen, U. Holmskov, A. Voss, 2009, The Journal of Rheumatology.

Localization of surfactant protein‐D in the rheumatoid synovial membrane

F. B. Sørensen, P. Junker, C. Varnum, 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Radiographic progression and remission rates in early rheumatoid arthritis – MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2010, Annals of the rheumatic diseases.

Effect of D-penicillamine on the mechanical properties of aorta, muscle tendon and skin in rats.

B. A. Jensen, H. Oxlund, T. Andreassen, 1984, Atherosclerosis.

Effect of D-penicillamine pre- and post-implantation treatment on formation of sponge-induced granulation tissue in rats.

P. Junker, I. Lorenzen, G. Helin, 1984, Scandinavian journal of rheumatology.

Serum amyloid P component-DNA complexes are decreased in systemic lupus erythematosus. inverse association with anti-dsDNA antibodies.

A. Voss, P. Junker, S. Svehag, 2008, Journal of Rheumatology.

Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trials

H. Thomsen, J. Baker, M. Østergaard, 2017, Annals of the rheumatic diseases.

Evaluation of the optimum dose of growth hormone (GH) for restoring bone mass in adult‐onset GH deficiency: results from two 12‐month randomized studies

C. Hagen, M. Andersen, H. C. Horn, 2002, Clinical endocrinology.

Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study.

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2006, Arthritis and rheumatism.

Reliability of the discrete choice experiment at the input and output level in patients with rheumatoid arthritis.

J. Lauridsen, P. Junker, U. Skjoldborg, 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Validity and Responsiveness of Combined Inflammation and Combined Joint Damage Scores Based on the OMERACT Rheumatoid Arthritis MRI Scoring System (RAMRIS)

P. Conaghan, M. Østergaard, P. Junker, 2019, The Journal of Rheumatology.

Low-cost, low-field dedicated extremity magnetic resonance imaging in early rheumatoid arthritis: a 1-year follow-up study

M. Østergaard, P. Junker, M Østergaard, 2006, Annals of the rheumatic diseases.

Cardiac Abnormalities in Adult Patients With Polymyositis or Dermatomyositis as Assessed by Noninvasive Modalities

S. Kay, J. Simonsen, L. Dreyer, 2016, Arthritis care & research.

Traditional Cardiovascular Risk Factors and Coronary Artery Calcification in Adults With Polymyositis and Dermatomyositis: A Danish Multicenter Study

S. Kay, J. Simonsen, I. Lundberg, 2015, Arthritis care & research.

Cartilage Oligomeric Matrix Protein Associates Differentially with Erosions and Synovitis and Has a Different Temporal Course in Cyclic Citrullinated Peptide Antibody (Anti-CCP)-positive versus Anti-CCP-negative Early Rheumatoid Arthritis

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2011, The Journal of Rheumatology.

The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression

W. Robinson, J. Sokolove, M. Østergaard, 2016, Arthritis Research & Therapy.

Newborn infant characteristics and risk of future rheumatoid arthritis: a twin-control study

K. Kyvik, A. Skytthe, G. Houen, 2014, Rheumatology International.

[Antiphospholipid antibodies and occlusive vascular disease].

P. Junker, A. M. Herskind, K. Christensen, 1993, Ugeskrift for laeger.

Reversibility of D-penicillamine induced collagen alterations in rat skin and granulation tissue.

P. Junker, I. Lorenzen, 1983, Biochemical pharmacology.

T-cell immunoglobulin and mucin domain 3 is upregulated in rheumatoid arthritis, but insufficient in controlling inflammation.

M. Oestergaard, K. Stengaard-Pedersen, M. Deleuran, 2022, American journal of clinical and experimental immunology.

Soluble CD206 plasma levels in rheumatoid arthritis reflect decrease in disease activity

H. Møller, M. Østergaard, K. Stengaard-Pedersen, 2017, Scandinavian journal of clinical and laboratory investigation.

A non-synonymous single-nucleotide polymorphism in the gene encoding Toll-like Receptor 3 (TLR3) is associated with sero-negative Rheumatoid Arthritis (RA) in a Danish population

Bettina Hansen, K. Stengaard-Pedersen, M. Laska, 2014, BMC Research Notes.

Cardiac abnormalities assessed by non-invasive techniques in patients with newly diagnosed idiopathic inflammatory myopathies.

S. Kay, J. Simonsen, I. Lundberg, 2015, Clinical and experimental rheumatology.

Renal crisis in asclerodermic scleroderma—lupus overlap syndrome

H. C. Horn, P. Junker, P. Ottosen, 2001, Lupus.

CONJOINT RELIABILITY INVESTIGATED AT THE INPUT AND OUTPUT LEVEL By

J. Lauridsen, P. Junker, U. Skjoldborg, 2006 .

Incidence of Chronic Persistent Rheumatoid Arthritis and the Impact of Smoking: A Historical Twin Cohort Study

K. Kyvik, A. Skytthe, G. Houen, 2016, Arthritis care & research.

Type I and III collagen turnover is increased in axial spondyloarthritis and psoriatic arthritis. Associations with disease activity and diagnostic capacity.

M. Karsdal, A. Loft, P. Junker, 2017, Clinical and experimental rheumatology.

On the Origin of Rheumatoid Arthritis: The Impact of Environment and Genes—A Population Based Twin Study

L. Christiansen, K. Christensen, K. Kyvik, 2013, PloS one.

CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients

M. Bøgsted, R. Steffensen, M. Østergaard, 2014, Arthritis Research & Therapy.

Different Cartilage Oligomeric Matrix Protein (COMP) Patterns in Untreated Anti-CCP Positive and Negative Rheumatoid Arthritis (RA)

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2009 .

Altered Antibody Response to Epstein-Barr Virus in Patients With Rheumatoid Arthritis and Healthy Subjects Predisposed to the Disease. A Twin Study

K. Kyvik, G. Houen, M. Westergaard, 2021, Frontiers in Immunology.

Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.

A. Voss, C. Nielsen, P. Junker, 1998, Arthritis and rheumatism.

P. Junker, M. Jakobsen, N. Lomborg, 2019, Scandinavian journal of rheumatology.

Dyslipedaemia in early rheumatoid arthritis is common and not influenced by two ears of effective DMARD therapy. The OPERA-study.

K. Stengaard-Pedersen, T. Ellingsen, P. Junker, 2012 .

Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort.

A. Voss, P. Junker, A. Green, 1998, Scandinavian journal of rheumatology.

Galectin‐3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti‐CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity

K. Stengaard-Pedersen, P. Junker, U. Tarp, 2017, Scandinavian journal of immunology.

Hypercalcemia in idiopathic myelofibrosis: Modulation of calcium and collagen homeostasis by 1,25‐dihydroxyvitamin D3

A. Voss, H. Hasselbalch, P. Junker, 1992, American journal of hematology.

A disintegrin and metalloprotease-17 and galectin-9 are important regulators of local 4-1BB activity and disease outcome in rheumatoid arthritis.

S. Moestrup, M. Østergaard, K. Stengaard-Pedersen, 2016, Rheumatology.

2015 ACR/ARHP Annual Meeting Abstract Supplement.

M. Bøgsted, G. Jones, K. Palmer, 2015, Arthritis & rheumatology.

Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis.

K. Majamaa, J. Risteli, K. Kivirikko, 1988, Clinical and experimental rheumatology.

Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms

M. Karsdal, H. Hasselbalch, P. Junker, 2023, Cancers.

Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis

M. Karsdal, A. Loft, P. Junker, 2016, Arthritis Research & Therapy.

OP0120 The incidence of rheumatoid arthritis and the impact of smoking

K. Kyvik, A. Skytthe, J. Hjelmborg, 2013 .

On the recurrence risk of arthritis among psoriatic patients

P. Junker, O. Pedersen, 2009, Scandinavian journal of rheumatology.

AB0648 Disease Mapping in Anca Associated Vasculitis (AAV). Yield of FDG-PET/CT Imaging Versus a Conventional Clinico-Pathological Approach,

S. Hess, H. Laustrup, P. Junker, 2015 .

Lymphocyte activation gene 3 is increased and affects cytokine production in rheumatoid arthritis

E. Hauge, M. Østergaard, K. Stengaard-Pedersen, 2023, Arthritis Research & Therapy.

Serum and urinary aminoterminal type III procollagen peptide in progressive systemic sclerosis: relationship to sclerodermal involvement, serum hyaluronan and urinary collagen metabolites.

P. Junker, K. Hørslev-Petersen, I. Lorenzen, 1988, The Journal of rheumatology.

The contingent ranking method--a feasible and valid method when eliciting preferences for health care?

Peter Junker, P. Junker, Ulla Slothuus, 2002, Social science & medicine.

M. Østergaard, K. Stengaard-Pedersen, T. Ellingsen, 2015, Annals of the rheumatic diseases.

Systemic adverse events following rituximab therapy in patients with Graves’ disease

L. Hegedüs, H. Hasselbalch, C. Nielsen, 2010, Journal of endocrinological investigation.

Tumour necrosis factor-α inhibitors are glucocorticoid-sparing in rheumatoid arthritis.

P. Junker, H. Lindegaard, A. Nilsson, 2011, Danish medical bulletin.

M. Østergaard, K. Stengaard-Pedersen, H. C. Horn, 2013, Annals of the rheumatic diseases.

MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2008, Annals of the rheumatic diseases.

M. Østergaard, K. Stengaard-Pedersen, J. K. Pedersen, 2017, Scandinavian journal of rheumatology.